Attached files
| file | filename |
|---|---|
| EX-31.4 - EXHIBIT 31.4 - Sorrento Therapeutics, Inc. | ex314.htm |
| EX-10.28 - EXHIBIT 10.28 - Sorrento Therapeutics, Inc. | ex1028.htm |
| 10-K/A - 10-K/A - Sorrento Therapeutics, Inc. | a10-kaproxy.htm |
Exhibit 31.3
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Henry Ji, certify that:
1. | I have reviewed this Amendment No. 1 to Annual Report on Form 10-K/A of Sorrento Therapeutics, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: April 25, 2018 | By: | /s/ Henry Ji |
Henry Ji, Ph.D. | ||
Chairman of the Board of Directors, Chief Executive Officer and President | ||
(Principal Executive Officer) | ||